Trials / Completed
CompletedNCT02245542
The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,775 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Study to assess efficacy, tolerability and safety parameters of a three month ALNA®OCAS® -treatment with special respect to nocturia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ALNA®OCAS® |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2006-02-01
- First posted
- 2014-09-19
- Last updated
- 2014-09-19
Source: ClinicalTrials.gov record NCT02245542. Inclusion in this directory is not an endorsement.